Cargando…
Hypersensitivity pneumonitis: a complex lung disease
Hypersensitivity pneumonitis (HP), also called extrinsic allergic alveolitis, is a respiratory syndrome involving the lung parenchyma and specifically the alveoli, terminal bronchioli, and alveolar interstitium, due to a delayed allergic reaction. Such reaction is secondary to a repeated and prolong...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5339989/ https://www.ncbi.nlm.nih.gov/pubmed/28286422 http://dx.doi.org/10.1186/s12948-017-0062-7 |
_version_ | 1782512761439256576 |
---|---|
author | Riario Sforza, Gian Galeazzo Marinou, Androula |
author_facet | Riario Sforza, Gian Galeazzo Marinou, Androula |
author_sort | Riario Sforza, Gian Galeazzo |
collection | PubMed |
description | Hypersensitivity pneumonitis (HP), also called extrinsic allergic alveolitis, is a respiratory syndrome involving the lung parenchyma and specifically the alveoli, terminal bronchioli, and alveolar interstitium, due to a delayed allergic reaction. Such reaction is secondary to a repeated and prolonged inhalation of different types of organic dusts or other substances to which the patient is sensitized and hyper responsive, primarily consisting of organic dusts of animal or vegetable origin, more rarely from chemicals. The prevalence of HP is difficult to evaluate because of uncertainties in detection and misdiagnosis and lacking of widely accepted diagnostic criteria, and varies considerably depending on disease definition, diagnostic methods, exposure modalities, geographical conditions, agricultural and industrial practices, and host risk factors. HP can be caused by multiple agents that are present in work places and in the home, such as microbes, animal and plant proteins, organic and inorganic chemicals. The number of environment, settings and causative agents is increasing over time. From the clinical point of view HP can be divided in acute/subacute and chronic, depending on the intensity and frequency of exposure to causative antigens. The mainstay in managing HP is the avoidance of the causative antigen, though the complete removal is not always possible due to the difficulties to identify the agent or because its avoidance may lead to major changes in life style or occupational settings. HP is a complex syndrome that needs urgently for more stringent and selective diagnostic criteria and validation, including wider panels of IgG, and a closer collaboration with occupational physicians, as part of a multidisciplinary expertise. |
format | Online Article Text |
id | pubmed-5339989 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-53399892017-03-10 Hypersensitivity pneumonitis: a complex lung disease Riario Sforza, Gian Galeazzo Marinou, Androula Clin Mol Allergy Review Hypersensitivity pneumonitis (HP), also called extrinsic allergic alveolitis, is a respiratory syndrome involving the lung parenchyma and specifically the alveoli, terminal bronchioli, and alveolar interstitium, due to a delayed allergic reaction. Such reaction is secondary to a repeated and prolonged inhalation of different types of organic dusts or other substances to which the patient is sensitized and hyper responsive, primarily consisting of organic dusts of animal or vegetable origin, more rarely from chemicals. The prevalence of HP is difficult to evaluate because of uncertainties in detection and misdiagnosis and lacking of widely accepted diagnostic criteria, and varies considerably depending on disease definition, diagnostic methods, exposure modalities, geographical conditions, agricultural and industrial practices, and host risk factors. HP can be caused by multiple agents that are present in work places and in the home, such as microbes, animal and plant proteins, organic and inorganic chemicals. The number of environment, settings and causative agents is increasing over time. From the clinical point of view HP can be divided in acute/subacute and chronic, depending on the intensity and frequency of exposure to causative antigens. The mainstay in managing HP is the avoidance of the causative antigen, though the complete removal is not always possible due to the difficulties to identify the agent or because its avoidance may lead to major changes in life style or occupational settings. HP is a complex syndrome that needs urgently for more stringent and selective diagnostic criteria and validation, including wider panels of IgG, and a closer collaboration with occupational physicians, as part of a multidisciplinary expertise. BioMed Central 2017-03-07 /pmc/articles/PMC5339989/ /pubmed/28286422 http://dx.doi.org/10.1186/s12948-017-0062-7 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Riario Sforza, Gian Galeazzo Marinou, Androula Hypersensitivity pneumonitis: a complex lung disease |
title | Hypersensitivity pneumonitis: a complex lung disease |
title_full | Hypersensitivity pneumonitis: a complex lung disease |
title_fullStr | Hypersensitivity pneumonitis: a complex lung disease |
title_full_unstemmed | Hypersensitivity pneumonitis: a complex lung disease |
title_short | Hypersensitivity pneumonitis: a complex lung disease |
title_sort | hypersensitivity pneumonitis: a complex lung disease |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5339989/ https://www.ncbi.nlm.nih.gov/pubmed/28286422 http://dx.doi.org/10.1186/s12948-017-0062-7 |
work_keys_str_mv | AT riariosforzagiangaleazzo hypersensitivitypneumonitisacomplexlungdisease AT marinouandroula hypersensitivitypneumonitisacomplexlungdisease |